Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis
Hematol Transfus Cell Ther
.
2024 Dec:46 Suppl 6:S427-S430.
doi: 10.1016/j.htct.2024.03.006.
Epub 2024 May 25.
Authors
André Dias Américo
1
,
Cinthya Correa Silva
2
,
Mariana Nassif Kerbauy
2
,
Leonardo Javier Arcuri
2
,
Andressa Alice Feitosa Ribeiro
2
,
Nelson Hamerschlak
2
,
Fábio Pires Souza Santos
2
Affiliations
1
Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil. Electronic address: andrediasamerico1989@gmail.com.
2
Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil.
PMID:
39095316
DOI:
10.1016/j.htct.2024.03.006
No abstract available
Publication types
Letter